ProTrials Research, Inc.TM, a leader in the clinical research organization industry, announced the Silicon Valley/San Jose Business Journal has chosen it as one of the area?s Top 50 Women-Owned Businesses for 2008. ProTrials placed seventh on the list that ranks area public and private women-owned companies according to revenue.
ProTrials Cracks the Top Ten in Silicon Valley’s Women-Owned Businesses Ranking
Company jumps to seventh based on increased revenues
Mountain View, CA – July 16, 2008 – ProTrials Research, Inc.TM, a leader in the clinical research organization industry, today announced the Silicon Valley/San Jose Business Journal has chosen it as one of the area’s Top 50 Women-Owned Businesses for 2008. ProTrials placed seventh on the list that ranks area public and private women-owned companies according to revenue.
“Jumping from number nine on last year’s list to seventh this year correlates to ProTrials’ accelerated business momentum and its ability to achieve significant milestones,” commented Jodi Andrews, ProTrials co-founder and CEO. “Our commitment to providing the best clinical trial services to our clients is key to this growth, and has resulted in higher visibility and increased sales. We are pleased that the Silicon Valley/San Jose Business Journal continues to recognize ProTrials’ success.”
ProTrials is the only clinical research organization to make the Silicon Valley/San Jose Business Journal top 50 and is one of only a handful of women-owned and operated CROs worldwide. It recently attained certification by the Women’s Business Enterprise National Council, an elite group of women-owned and operated businesses. In 2007, ProTrials achieved a ranking on the Inc. 5000, a list that recognizes the fastest-growing private companies in the United States.
About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a specialized clinical research organization (CRO) with regional clinical research associates and project managers based throughout North America, Canada, and Europe. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing cost-effective site monitoring, project management and associated clinical operations services. ProTrials is headquartered in Mountain View, California. For more information, visit www.protrials.com <http://www.protrials.com/> or call (650) 864-9180.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.